These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15716701)

  • 41. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E; Rizzoni D
    Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men.
    Brixius K; Middeke M; Lichtenthal A; Jahn E; Schwinger RH
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):327-31. PubMed ID: 17324145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nebivolol in the management of essential hypertension: a review.
    McNeely W; Goa KL
    Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats.
    Ye H; Ling S; Castillo AC; Thomas B; Long B; Qian J; Perez-Polo JR; Ye Y; Chen X; Birnbaum Y
    Hypertension; 2013 May; 61(5):1008-13. PubMed ID: 23460283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Functional and biochemical characteristics of the vasodilator effects of nebivolol in patients with arterial hypertension].
    Gel'tser BI; Kotel'niko v VN; Savchenko SV
    Ter Arkh; 2002; 74(12):34-7. PubMed ID: 12577837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
    Vitale C; Marazzi G; Iellamo F; Spoletini I; Dall'Armi V; Fini M; Volterrani M
    Int J Cardiol; 2012 Mar; 155(2):279-84. PubMed ID: 22078979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.
    Okamoto LE; Gamboa A; Shibao CA; Arnold AC; Choi L; Black BK; Raj SR; Robertson D; Biaggioni I
    Hypertension; 2014 Dec; 64(6):1241-7. PubMed ID: 25267802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway.
    Wang Y; Niu M; Yin S; Zhang F; Shi R
    Pharmacol Rep; 2018 Oct; 70(5):917-929. PubMed ID: 30099298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress.
    Hayek SS; Poole JC; Neuman R; Morris AA; Khayata M; Kavtaradze N; Topel ML; Binongo JG; Li Q; Jones DP; Waller EK; Quyyumi AA
    J Am Soc Hypertens; 2015 Mar; 9(3):206-13. PubMed ID: 25681236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A dose-response trial of nebivolol in essential hypertension.
    Van Nueten L; Dupont AG; Vertommen C; Goyvaerts H; Robertson JI
    J Hum Hypertens; 1997 Feb; 11(2):139-44. PubMed ID: 9140802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
    Giles TD; Weber MA; Basile J; Gradman AH; Bharucha DB; Chen W; Pattathil M;
    Lancet; 2014 May; 383(9932):1889-98. PubMed ID: 24881993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
    Mahmud A; Feely J
    Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autonomic effects of nebivolol versus atenolol in healthy subjects.
    Chiladakis JA; Georgiopoulou E; Alexopoulos D
    Cardiovasc Drugs Ther; 2004 Nov; 18(6):469-73. PubMed ID: 15770434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease.
    Galderisi M; Cicala S; D'Errico A; de Divitiis O; de Simone G
    J Hypertens; 2004 Nov; 22(11):2201-8. PubMed ID: 15480106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetics with mild to moderate hypertension.
    Peter P; Martin U; Sharma A; Dunne F
    J Clin Pharm Ther; 2006 Apr; 31(2):153-9. PubMed ID: 16635049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans.
    Mason RP; Kalinowski L; Jacob RF; Jacoby AM; Malinski T
    Circulation; 2005 Dec; 112(24):3795-801. PubMed ID: 16330685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
    Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension.
    Kandavar R; Higashi Y; Chen W; Blackstock C; Vaughn C; Sukhanov S; Sander GE; Roffidal LE; Delafontaine P; Giles TD
    J Am Soc Hypertens; 2011; 5(3):161-5. PubMed ID: 21251896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.